# ZTO Express (Cayman) Inc.: financial statements, quarterly

ZTO · NYSE · CIK 1677250 · [Industrials](/sectors/industrials.md)

Pages: [Overview](/companies/zto.md) · [Financials](/companies/zto/financials.md) · [Filings](/companies/zto/filings.md) · [Insiders](/companies/zto/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zto/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-12-31) | FY2016 (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001104659-17-026948.md) | [1.6](/filings/0001104659-17-026948.md) | [0.8](/filings/0001104659-18-025967.md) | [0.7](/filings/0001104659-19-021667.md) | [0.8](/filings/0001104659-20-049056.md) | [2.2](/filings/0001104659-21-052844.md) | [1.5](/filings/0001104659-22-051510.md) | [1.7](/filings/0001104659-23-047358.md) | [1.7](/filings/0001104659-24-049017.md) | [1.8](/filings/0001410578-25-000774.md) | [1.4](/filings/0001104659-26-044613.md) |
| Current assets | $bn | not reported | [1.9](/filings/0001104659-17-026948.md) | [1.9](/filings/0001104659-18-025967.md) | [3.1](/filings/0001104659-19-021667.md) | [2.9](/filings/0001104659-20-049056.md) | [3.4](/filings/0001104659-21-052844.md) | [2.9](/filings/0001104659-22-051510.md) | [3.5](/filings/0001104659-23-047358.md) | [3.8](/filings/0001104659-24-049017.md) | [4.2](/filings/0001410578-25-000774.md) | [4.9](/filings/0001104659-26-044613.md) |
| Total assets | $bn | not reported | [3.4](/filings/0001104659-17-026948.md) | [4.0](/filings/0001104659-18-025967.md) | [5.8](/filings/0001104659-19-021667.md) | [6.6](/filings/0001104659-20-049056.md) | [9.1](/filings/0001104659-21-052844.md) | [9.9](/filings/0001104659-22-051510.md) | [11.4](/filings/0001104659-23-047358.md) | [12.5](/filings/0001104659-24-049017.md) | [12.7](/filings/0001410578-25-000774.md) | [13.0](/filings/0001104659-26-044613.md) |
| Current liabilities | $bn | not reported | [0.5](/filings/0001104659-17-026948.md) | [0.6](/filings/0001104659-18-025967.md) | [0.7](/filings/0001104659-19-021667.md) | [1.0](/filings/0001104659-20-049056.md) | [1.4](/filings/0001104659-21-052844.md) | [2.0](/filings/0001104659-22-051510.md) | [2.4](/filings/0001104659-23-047358.md) | [2.8](/filings/0001104659-24-049017.md) | [3.9](/filings/0001410578-25-000774.md) | [3.3](/filings/0001104659-26-044613.md) |
| Total liabilities | $bn | not reported | [0.5](/filings/0001104659-17-026948.md) | [0.7](/filings/0001104659-18-025967.md) | [0.8](/filings/0001104659-19-021667.md) | [1.1](/filings/0001104659-20-049056.md) | [1.5](/filings/0001104659-21-052844.md) | [2.2](/filings/0001104659-22-051510.md) | [3.5](/filings/0001104659-23-047358.md) | [4.0](/filings/0001104659-24-049017.md) | [4.1](/filings/0001410578-25-000774.md) | [3.4](/filings/0001104659-26-044613.md) |
| Short-term borrowings | $bn | not reported | [0.1](/filings/0001104659-17-026948.md) | [0.0](/filings/0001104659-18-025967.md) | not reported | not reported | [0.2](/filings/0001104659-21-052844.md) | [0.5](/filings/0001104659-22-051510.md) | [0.8](/filings/0001104659-23-047358.md) | [1.1](/filings/0001104659-24-049017.md) | [1.3](/filings/0001410578-25-000774.md) | [1.6](/filings/0001104659-26-044613.md) |
| Shareholders' equity | $bn | not reported | [2.8](/filings/0001104659-17-026948.md) | [3.3](/filings/0001104659-18-025967.md) | [5.0](/filings/0001104659-19-021667.md) | [5.5](/filings/0001104659-20-049056.md) | [7.5](/filings/0001104659-21-052844.md) | [7.6](/filings/0001104659-22-051510.md) | [7.8](/filings/0001104659-23-047358.md) | [8.4](/filings/0001104659-24-049017.md) | [8.5](/filings/0001410578-25-000774.md) | [9.5](/filings/0001104659-26-044613.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.